ReviewACS pharmacology & translational science2024

Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer's Disease Therapeutics.

Ben Boyarko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.